Financial Year |
March 31 2023 |
Monetary Funds |
775,407,510.91 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
-- |
Accounts Receivable |
222,217,119.81 |
Advances to Suppliers |
23,747,543.06 |
Other Receivables |
8,415,324.28 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
112,871.00 |
Dividend Receivable |
-- |
Inventories |
715,199,399.44 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
73,063,726.16 |
Total Current Assets |
1,924,649,567.02 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
1,650,660,121.92 |
Under-construction Projects |
19,553,590.58 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
1,754,638.46 |
Oil and Gas Assets |
-- |
Intangible Assets |
248,318,367.33 |
R&D expenses |
-- |
Goodwill |
36,163,838.10 |
Long-Term Deferred and Prepaid Expenses |
13,518,689.39 |
Deferred Income Tax Assets |
901,347.46 |
Other Non-Current Assets |
6,331,000.70 |
Sub-Total of Non-Current Assets |
2,093,380,519.23 |
Total Assets |
4,018,030,086.25 |
Short-Term Loans |
270,192,625.00 |
Trading Financial liabilities |
-- |
Notes Payable |
19,540,977.49 |
Accounts Payable |
377,875,337.32 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
1,252,723.44 |
Taxes Payable |
10,372,069.21 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
13,681,771.81 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
7,743,876.16 |
Other Current Liabilities |
2,734,427.12 |
Sub-Total of Current Liabilities |
722,273,435.73 |
Long-term Loans |
441,000,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
11,037,553.38 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
491,855,456.91 |
Total Liabilities |
1,214,128,892.64 |
Paid-In Capital(Or Share Stock) |
1,145,622,800.00 |
Capital Surplus |
752,855,248.07 |
Surplus Reserve |
159,271,575.10 |
LESS:Treasury Stock |
75,808,961.64 |
Undistributed Profits |
817,453,516.62 |
Minority Stockholder's Interest |
4,082,428.10 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,799,818,765.51 |
Owner's Equity(Stockholder's Equity) |
2,803,901,193.61 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,018,030,086.25 |